Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04906707 · ClinicalTrials.gov registry record · NA
Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT04906707 is a NA study that has completed, run by Emory University. The registered enrollment target is 44 participants.
The verdict
NCT04906707, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.
Interventions
- DEVICE EaseVRx
- BEHAVIORAL Audio-only version of EaseVRx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2021-10-27 |
| Est. Completion | 2024-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04906707
The ClinicalTrials.gov registry entry for NCT04906707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EaseVRx is the first listed.
NCT04906707 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04906707 about?
NCT04906707 is a clinical study titled "Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease". This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.
What is the current status of trial NCT04906707?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2021-10-27. Estimated completion is 2024-03-05.
What interventions are being tested in trial NCT04906707?
The interventions under investigation include: EaseVRx (DEVICE), Audio-only version of EaseVRx (BEHAVIORAL).
Who is sponsoring clinical trial NCT04906707?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.